SEALLS (Sealing Evaluation of Air Leaks After Lung Surgery) Trial Using HEMOPATCH

    Not Recruiting
  • participants needed
  • sponsor
    Quirón Madrid University Hospital
Updated on 23 January 2021
Javier Moradiellos, MD
Primary Contact
Quir nsalud Madrid University Hospital (3.9 mi away) Contact


The primary objective is to assess the efficacy and safety of HEMOPATCH Sealing Hemostat in reducing the incidence and duration of air leaks after lung resection compared to standard techniques.

Hypothesis: "The routine application of HEMOPATCH Sealing Hemostat on the visceral pleura in lung resection areas, during lung resection procedures, is more EFFICIENT to reduce the incidence and duration of prolonged air leaks as compared to standard surgical measures."

Condition Pulmonary Disease
Treatment Hemopatch™ Sealing Hemostat, Standard surgical technique
Clinical Study IdentifierNCT02668978
SponsorQuirón Madrid University Hospital
Last Modified on23 January 2021

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note